BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that Peter Lichtlen, M.D., Ph.D., has joined its wholly-owned subsidiary Sucampo AG as Senior Medical Officer and Vice President of European Operations. Dr. Lichtlen, formerly Head, Clinical R&D, at ESBATech AG, will provide leadership and guidance to clinical development activities in the U.S. and Europe and lead the European operations. He also will be responsible for overseeing the Medical Affairs teams and advising the global Pharmacovigilance teams. Dr. Lichtlen will report to James J. Egan, Chief Operating Officer, and Gayle R. Dolecek, P.D., M.P.H., Senior Vice President, Research & Development.
